Table 2.
pwINS baseline
| Exposed (N = 24) | Controls (N = 23) | Total (N = 47) | P | |
|---|---|---|---|---|
| Illness duration (years) | ||||
| Mean ± SD | 11.6 ± 12.3 | 19.7 ± 17.9 | 15.6 ± 15.6 | 0.080a |
| Median [range] | 6.2 [0.0, 39.3] | 15.1 [1.1, 55.3] | 9.9 [0, 55.3] | |
| Familiarity for insomnia, N (%)c | ||||
| No | 19 (79.2%) | 13 (59.1%) | 32 (69.6%) | 0.139b |
| Yes | 5 (20.8%) | 9 (40.9%) | 14 (30.4%) | |
| Sleep hygiene in use, N (%) | ||||
| No | 8 (33.3%) | 10 (43.5%) | 18 (33.3%) | 0.474b |
| Yes | 16 (66.7%) | 13 (56.5%) | 29 (61.7%) | |
| Therapy pre-study, N (%) | ||||
| None | 6 (25.0%) | 2 (8.7%) | 8 (17.0%) | |
| Melatonin ± anxiolytic | 3 (12.5%) | 4 (17.4%) | 7 (14.9%) | |
| Benzodiazepines | 9 (37.5%) | 8 (34.8%) | 17 (14.9%) | |
| Antidepressant ± analgesic | 3 (12.5%) | 4 (17.4%) | 7 (14.9%) | |
| Antidepressant + benzodiazepine | 3 (12.5%) | 5 (21.7%) | 8 (17.0%) | |
aWelch–Satterthwaite t test
bChi square test
c1 N/A among control